On October 28, CMS requested public comment on four proposed information collections (ICRs) it intends to impose on drug manufacturers and pharmacies in order to effectuate maximum fair prices (MFP) under the Inflation Reduction Act (IRA’s) Medicare Drug Price Negotiation Program for initial price applicability year (IPAY) 2026 and IPAY 2027….
By: Manatt, Phelps & Phillips, LLP
By: Manatt, Phelps & Phillips, LLP